Portable, eco-friendly and entirely 3D-printed artificial lung ventilator (ALV) developed by Slovak scientists, intended for regions with limited access to healthcare. The project is going to be implemented in Kenya throughout 2021-2023 by the TATRASKY startup, Comenius University in Bratislava (platform FURKABREATH), the University of Nairobi and the Slovak Agency for International Development Cooperation - SlovakAid.
Q-vent is manufactured using solely 3D printing technology. This production method is designed to allow for the manufacture of Q-vent directly in Kenya by the local community using locally-available raw materials.
The device is environmentally friendly, as it is made from recycled materials and is fully biodegradable. Q-vent thus contributes to the crucial United Nations SDG (Sustainable Development Goal) 13: "Climate protection."
Production instructions, as well as the original scientific study from which the Q-vent project evolved into its current form, have been published in a prestigious American scientific journal. See for yourself.
The production cost of Q-vent designed for bridging therapy is approximately 100 times lower than the conventionally used ALV and more than 15 times lower than the cheapest available bridging ventilators. The components have been designed and optimized for facile repair. Most require the available 3D printer and a PC.
This device is produced with respect to CE, FCC and other modern standards, while the validation is carried out according to the testing procedure established by United Kingdom’s Medicines and Healthcare products Regulatory Agency. Q-vent successfully passed the RMVS001 validation.
The device integrates all of the important modules common across commercially available ALVs. These include a heater, humidifier, adjustable oxygen fraction, as well as cough, pressure and flow sensors.
The revolutionary antimicrobial material developed by the scientific team within the project supported by the Ministry of Foreign and European Affairs of the Slovak Republic and the Slovak-Aid agency is another exceptional feature. Read the open-source instructions and the antimicrobial study on this novel material in a renowned British cutting-edge scientific journal.
Experts
Mgr. Samuel Furka, PhD. - CEO /SR
Mgr. Daniel Furka, PhD. - CEO /SR
JUDr. MUDr. Patrik Palacka MBA. MPh. PhD. LL.M. - CEO /SR
MUDr. Ján Slopovský/SR
Mgr. Dominika Hromníková, PhD. /SR
Doc. Ing. Marián Janek, PhD. /SR
Mgr. Vladimír Heger, PhD. /SR
DR. Jared O. Mecha, MBChB. MMed. MSc-RM. /KE
Bc. Paul Ali Boru - TATRASKY CEO /KE
Dr. Rose Wangeci Wanjohi, BDS. MPHh. /KE
Staff and and volunteers
Mgr. Ondrej Ružička, PhD. /SR
MUDr. Zuzana Eľková /SR
Bc. Kristína Filipeje /SR
Bc. Branislava Štefančinová /SR
MUC. Adam Čúzy /SR
MUC. Adam Salama /SR , IZR
MUC. Hamid Himat /SR, AFG
There are several interesting numerical indicators characterizing the SAMRS/2021/KE/1/5 project, which we want to share with you. You can find them below. Furthermore, we chose to collaborate with Kenya. Why? Because the country's vastness and rapidly-evolving healthcare requires it. If you want to participate, please contact info@tatrasky.com.
Parts printed
views of the
project
Breaths of
Q-vents
